Correlation Between Corvus Pharmaceuticals and Fluoropharma Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Fluoropharma Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Fluoropharma Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Fluoropharma Medical, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Fluoropharma Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Fluoropharma Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Fluoropharma Medical.

Diversification Opportunities for Corvus Pharmaceuticals and Fluoropharma Medical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Corvus and Fluoropharma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Fluoropharma Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fluoropharma Medical and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Fluoropharma Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fluoropharma Medical has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Fluoropharma Medical go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Fluoropharma Medical

If you would invest  490.00  in Corvus Pharmaceuticals on October 25, 2024 and sell it today you would earn a total of  54.00  from holding Corvus Pharmaceuticals or generate 11.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy90.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Fluoropharma Medical

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Corvus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Fluoropharma Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fluoropharma Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Fluoropharma Medical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Corvus Pharmaceuticals and Fluoropharma Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Fluoropharma Medical

The main advantage of trading using opposite Corvus Pharmaceuticals and Fluoropharma Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Fluoropharma Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fluoropharma Medical will offset losses from the drop in Fluoropharma Medical's long position.
The idea behind Corvus Pharmaceuticals and Fluoropharma Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings